Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit: the QuitNic pilot trial

Olivia Wynne; Victoria  Manning; Coral Gartner; Dan I. Lubman; Amanda L. Baker; Cathy Segan; Donita Baird; Ron Borland; Eliza Skelton; Ashleigh Guillaumier; Billie Bonevski

doi:10.1111/dar.12862

Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit: the QuitNic pilot trial

Olivia Wynne
, Victoria Manning
, Coral Gartner
, Dan I. Lubman
, Amanda L. Baker
, Cathy Segan
, Donita Baird
, Ron Borland
, Eliza Skelton
, Ashleigh Guillaumier
, Billie Bonevski

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Introduction
In Australia, up to 95% of people entering AOD treatment smoke tobacco, which is five times greater than for the general adult population. Smokers receiving AOD treatment are interested in quitting and make quit attempts, however heavy nicotine dependence among these smokers contributes to high relapse rates. The purpose of this pilot trial is to explore the feasibility, acceptability, adherence and potential effectiveness of two forms of smoking cessation support for AOD clients following discharge from care.

Original language	English
Article number	Presentation 3
Pages (from-to)	s6-s7
Number of pages	2
Journal	Drug and Alcohol Review
Volume	37
Issue number	S3
DOIs	https://doi.org/10.1111/dar.12862
Publication status	Published - Nov 2018
Externally published	Yes
Event	2018 Australasian Professional Society on Alcohol and other Drugs Conference - Auckland, New Zealand Duration: 4 Nov 2018 → 7 Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Conference presentation
Conference abstract
APSAD
APSAD 2018 Conference
Vaporised nicotine products
E-cigarettes
VNPs
Smoking cessation
Smoking cessation support
Quitline
QuitNic pilot trial
Nicotine Replacement Therapy (NRT)
Substance use disorder (SUD)

Access to Document

10.1111/dar.12862Licence: In Copyright

Cite this

Wynne, O., Manning, V., Gartner, C., Lubman, D. I., Baker, A. L., Segan, C., Baird, D., Borland, R., Skelton, E., Guillaumier, A., & Bonevski, B. (2018). Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit: the QuitNic pilot trial. Drug and Alcohol Review, 37(S3), s6-s7. Article Presentation 3. https://doi.org/10.1111/dar.12862

@article{f8495d8e027347ebb36aac6fced32a5d,

title = "Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit: the QuitNic pilot trial",

abstract = "Introduction In Australia, up to 95\% of people entering AOD treatment smoke tobacco, which is five times greater than for the general adult population. Smokers receiving AOD treatment are interested in quitting and make quit attempts, however heavy nicotine dependence among these smokers contributes to high relapse rates. The purpose of this pilot trial is to explore the feasibility, acceptability, adherence and potential effectiveness of two forms of smoking cessation support for AOD clients following discharge from care.",

keywords = "Conference presentation, Conference abstract, APSAD, APSAD 2018 Conference, Vaporised nicotine products, E-cigarettes, VNPs, Smoking cessation, Smoking cessation support, Quitline, QuitNic pilot trial, Nicotine Replacement Therapy (NRT), Substance use disorder (SUD)",

author = "Olivia Wynne and Victoria Manning and Coral Gartner and Lubman, \{Dan I.\} and Baker, \{Amanda L.\} and Cathy Segan and Donita Baird and Ron Borland and Eliza Skelton and Ashleigh Guillaumier and Billie Bonevski",

year = "2018",

month = nov,

doi = "10.1111/dar.12862",

language = "English",

volume = "37",

pages = "s6--s7",

journal = "Drug and Alcohol Review",

issn = "0959-5236",

publisher = "John Wiley \& Sons, Inc",

number = "S3",

note = "2018 Australasian Professional Society on Alcohol and other Drugs Conference, APSAD 2018 ; Conference date: 04-11-2018 Through 07-11-2018",

}

Wynne, O, Manning, V, Gartner, C, Lubman, DI, Baker, AL, Segan, C, Baird, D, Borland, R, Skelton, E, Guillaumier, A & Bonevski, B 2018, 'Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit: the QuitNic pilot trial', Drug and Alcohol Review, vol. 37, no. S3, Presentation 3, pp. s6-s7. https://doi.org/10.1111/dar.12862

TY - JOUR

T1 - Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit

T2 - 2018 Australasian Professional Society on Alcohol and other Drugs Conference

AU - Wynne, Olivia

AU - Manning, Victoria

AU - Gartner, Coral

AU - Lubman, Dan I.

AU - Baker, Amanda L.

AU - Segan, Cathy

AU - Baird, Donita

AU - Borland, Ron

AU - Skelton, Eliza

AU - Guillaumier, Ashleigh

AU - Bonevski, Billie

PY - 2018/11

Y1 - 2018/11

N2 - Introduction In Australia, up to 95% of people entering AOD treatment smoke tobacco, which is five times greater than for the general adult population. Smokers receiving AOD treatment are interested in quitting and make quit attempts, however heavy nicotine dependence among these smokers contributes to high relapse rates. The purpose of this pilot trial is to explore the feasibility, acceptability, adherence and potential effectiveness of two forms of smoking cessation support for AOD clients following discharge from care.

AB - Introduction In Australia, up to 95% of people entering AOD treatment smoke tobacco, which is five times greater than for the general adult population. Smokers receiving AOD treatment are interested in quitting and make quit attempts, however heavy nicotine dependence among these smokers contributes to high relapse rates. The purpose of this pilot trial is to explore the feasibility, acceptability, adherence and potential effectiveness of two forms of smoking cessation support for AOD clients following discharge from care.

KW - Conference presentation

KW - Conference abstract

KW - APSAD

KW - APSAD 2018 Conference

KW - Vaporised nicotine products

KW - E-cigarettes

KW - VNPs

KW - Smoking cessation

KW - Smoking cessation support

KW - Quitline

KW - QuitNic pilot trial

KW - Nicotine Replacement Therapy (NRT)

KW - Substance use disorder (SUD)

UR - https://apsadconference2021.com.au/abstract-submissions/

U2 - 10.1111/dar.12862

DO - 10.1111/dar.12862

M3 - Meeting Abstract

SN - 0959-5236

VL - 37

SP - s6-s7

JO - Drug and Alcohol Review

JF - Drug and Alcohol Review

IS - S3

M1 - Presentation 3

Y2 - 4 November 2018 through 7 November 2018

ER -

Vaporised nicotine products for smoking cessation following discharge from a residential withdrawal unit: the QuitNic pilot trial

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this